PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Programa de Oncovirologia, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil.\', \'Programa de Oncovirologia, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil; Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10 Room 6A08, 9000 Rockville Pike, Bethesda, MD 20892, USA.\', \'Hospital do Câncer II, Instituto Nacional de Câncer, Avenida Via Binário do Porto, 831, Rio de Janeiro, RJ 20081-250, Brazil.\', \'Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Building 10 Room 6A08, 9000 Rockville Pike, Bethesda, MD 20892, USA.\', \'Programa de Imunologia e Biologia de Tumores, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil.\', \'Programa de Oncovirologia, Instituto Nacional de Câncer, Rua Andre Cavalcanti, 37, Rio de Janeiro, RJ 20231-050, Brazil; Departamento de Genética, Universidade Federal do Rio de Janeiro, Av. Carlos Chagas Filho, 373, Rio de Janeiro, RJ 21941-402, Brazil. Electronic address: masoares@inca.gov.br.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1567-1348(21)00069-110.1016/j.meegid.2021.104772
?:hasPublicationType
?:journal
  • Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33592317
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Distinguishing SARS-CoV-2 bonafide re-infection from pre-existing minor variant reactivation.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all